Phase I Study of HAL Formulations Applied to the Cervix in Healthy Volunteers
This study has been terminated.
Information provided by:
First received: July 3, 2007
Last updated: January 15, 2009
Last verified: January 2009
The purpose of the study is to determine the most effective formulation of HAL for release of hexaminolevulinate to the cervical epithelium at different doses.
|Study Design:||Time Perspective: Prospective|
|Official Title:||A Phase I Hexaminolevulinate (HAL) Dose-Finding Study Applying Different Formulations to the Cervix in Healthy Volunteers|
Further study details as provided by PhotoCure:
Contacts and Locations